TERT and hepatocellular carcinoma: The Kaplan-Meier survival analysis indicated that TERT promoter mutations were associated with reduced recurrence-free survival of patients with HCC (P = 0.001, Log-rank test) (Figure 1C), which was further confirmed by multivariate analysis after adjustment for classical clinicopathologic risk factors.